Literature DB >> 17671056

Pediatric encephalitis: what is the role of Mycoplasma pneumoniae?

Laura J Christie1, Somayeh Honarmand, Deborah F Talkington, Shilpa S Gavali, Chris Preas, Chao-Yang Pan, Shigeo Yagi, Carol A Glaser.   

Abstract

BACKGROUND: Encephalitis is a complex, debilitating, and sometimes fatal neurologic condition to which children are especially prone. Mycoplasma pneumoniae, a common respiratory pathogen, has been implicated as an etiology of encephalitis. Evidence for recent or acute M. pneumoniae infection has been demonstrated in limited studies of both pediatric and adult patients with encephalitis. PATIENTS AND METHODS: Unexplained encephalitis cases are referred to the California Encephalitis Project for diagnostic testing. Serum, cerebrospinal fluid, and respiratory specimens are tested by polymerase chain reaction and serology methods for the presence of multiple pathogens, including M. pneumoniae. M. pneumonia-associated cases of encephalitis were compared with other bacterial agents, herpes simplex virus 1, and enterovirus.
RESULTS: Of 1988 patients referred to the California Encephalitis Project, evidence of acute M. pneumoniae infection was found in 111 patients, of which 84 (76%) were pediatric patients. Eighty percent of the 84 patients were positive for M. pneumoniae by serology alone. Cerebrospinal fluid polymerase chain reaction for M. pneumoniae was rarely positive (2%). Patients with M. pneumoniae-associated pediatric encephalitis were a median of 11 years old, progressed rapidly (median: 2 days from onset to hospitalization), and were often in the ICU (55%). Symptoms included fever (70%), lethargy (68%), and altered consciousness (58%). Gastrointestinal (45%) and respiratory (44%) symptoms were less common. Compared with patients with other bacterial as well as viral agents, patients with M. pneumoniae-associated encephalitis had fewer seizures and less-severe hospital courses.
CONCLUSIONS: M. pneumoniae is the most common agent implicated in the California Encephalitis Project. Patients with M. pneumoniae-associated encephalitis are predominantly pediatric, and their presentations are clinically similar to enterovirus encephalitis, although they frequently require intensive care with prolonged hospitalizations. Given that M. pneumoniae infection is found more than any other pathogen, increased emphasis should be placed on elucidating the role and mechanism of M. pneumoniae in encephalitis.

Entities:  

Mesh:

Year:  2007        PMID: 17671056     DOI: 10.1542/peds.2007-0240

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  25 in total

1.  Expression of Mycoplasma proteins carrying an affinity tag in M. pneumoniae allows rapid purification and circumvents problems related to the aberrant genetic code.

Authors:  Sebastian R Schmidl; Claudine Hames; Jörg Stülke
Journal:  Appl Environ Microbiol       Date:  2007-10-12       Impact factor: 4.792

2.  Prospective Cohort Study of Next-Generation Sequencing as a Diagnostic Modality for Unexplained Encephalitis in Children.

Authors:  Julia C Haston; Christina A Rostad; Robert C Jerris; Sarah S Milla; Courtney McCracken; Catherine Pratt; Michael Wiley; Karla Prieto; Gustavo Palacios; Andi L Shane; Anita K McElroy
Journal:  J Pediatric Infect Dis Soc       Date:  2020-07-13       Impact factor: 3.164

3.  Chronic meningitis with intracranial hypertension and bilateral neuroretinitis following Mycoplasma pneumoniae infection.

Authors:  Konstantinos Karampatsas; Himanshu Patel; Sheikh N Basheer; Andrew J Prendergast
Journal:  BMJ Case Rep       Date:  2014-12-23

4.  Mycoplasma pneumoniae: Innocent Bystander or a True Cause of Central Nervous System Disease?

Authors:  Ari Bitnun; Susan E Richardson
Journal:  Curr Infect Dis Rep       Date:  2010-07       Impact factor: 3.725

Review 5.  New insights into the pathogenesis and detection of Mycoplasma pneumoniae infections.

Authors:  Ken B Waites; Mitchell F Balish; T Prescott Atkinson
Journal:  Future Microbiol       Date:  2008-12       Impact factor: 3.165

6.  Anti-NMDA receptor encephalitis: report of ten cases and comparison with viral encephalitis.

Authors:  M S Gable; S Gavali; A Radner; D H Tilley; B Lee; L Dyner; A Collins; A Dengel; J Dalmau; C A Glaser
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-08-29       Impact factor: 3.267

7.  Role of Mycoplasma pneumoniae in pediatric encephalitis.

Authors:  C Domenech; N Leveque; B Lina; F Najioullah; D Floret
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-07-15       Impact factor: 3.267

8.  Functional status of children with encephalitis in an inpatient rehabilitation setting: a case series.

Authors:  Yogita I Tailor; Stacy J Suskauer; Leigh N Sepeta; Joshua B Ewen; Ellen J Dematt; Melissa K Trovato; Cynthia F Salorio; Beth S Slomine
Journal:  J Pediatr Rehabil Med       Date:  2013

9.  Encephalitis Surveillance through the Emerging Infections Program, 1997-2010.

Authors:  Karen C Bloch; Carol A Glaser
Journal:  Emerg Infect Dis       Date:  2015-09       Impact factor: 6.883

10.  Global secretome characterization of A549 human alveolar epithelial carcinoma cells during Mycoplasma pneumoniae infection.

Authors:  Shuxian Li; Xuejing Li; Yingshuo Wang; Jun Yang; Zhimin Chen; Shigang Shan
Journal:  BMC Microbiol       Date:  2014-02-07       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.